Lingo-1 Knockout Mice Development Service
Accelerate Your Neurological Drug Discovery! Are you currently facing challenges in understanding the complex pathophysiology of essential tremor, identifying novel drug targets, or efficiently screening potential therapeutic compounds? Our Lingo-1 knockout mice service helps you accelerate drug discovery, gain profound mechanistic insights, and validate therapeutic strategies through advanced genetic modeling and comprehensive preclinical evaluation.
Essential Tremor (ET) is a widespread neurological movement disorder, often linked to cerebellar dysfunction and genetic factors. The Lingo-1 protein, a negative regulator of neuronal survival, axon regeneration, and myelination, has been implicated in ET pathogenesis through genetic associations and elevated expression in patient brains. Lingo-1 knockout mouse models offer a critical tool to investigate these mechanisms, demonstrating increased axon integrity and providing a platform to test novel therapies targeting Lingo-1, thereby opening new avenues for ET treatment.
How Our ET Lingo-1 Knockout Mice Can Assist Your Project
At Creative Biolabs, our Lingo-1 knockout mice service provides a robust and physiologically relevant platform to advance your research into this debilitating neurological disorder. We offer specific deliverables that translate directly into actionable insights for your drug discovery pipeline. You can expect:
- Mechanistic Elucidation: A clearer understanding of Lingo-1's precise role in ET pathophysiology and its impact on neuronal integrity and function.
- Target Validation: Definitive evidence supporting Lingo-1 as a viable therapeutic target for ET, reducing development risks.
- Preclinical Efficacy Assessment: Robust data on the efficacy of your novel compounds in a relevant in vivo model, guiding lead optimization.
- Accelerated Lead Generation: A streamlined process for identifying and prioritizing promising drug candidates.
Discover How We Can Help - Request a Consultation
Workflow: From Concept to Breakthrough
Our workflow is designed for clarity, efficiency, and scientific rigor, ensuring a seamless experience from project initiation to final data delivery. This comprehensive process is ideal for visualization as a flowchart, making every step transparent for our clients.
- Required Starting Materials:
To initiate your project, clients typically provide:
- Project Scope and Objectives: A detailed outline of your research goals, specific hypotheses to be tested, and desired outcomes.
- Compound Information (if applicable): Details on any therapeutic compounds to be tested, including their mechanism of action, desired dosing regimens, and safety profiles.
- Existing Preliminary Data: Any relevant in vitro or preliminary in vivo data that can inform experimental design and power calculations.
- Final Deliverables:
Upon project completion, you will receive:
- Comprehensive Study Report: A detailed document summarizing all experimental procedures, raw data, analyzed results, statistical interpretations, and scientific conclusions.
- Raw and Analyzed Data Files: All primary data files (e.g., video recordings of behavior, imaging files, quantitative PCR data) and processed data in a user-friendly format.
- Presentation of Key Findings: A scientific presentation summarizing the most critical results and their implications, suitable for internal review or stakeholder briefings.
- Estimated Timeframe:
The typical timeframe for a comprehensive Lingo-1 knockout mice study ranges from 16 to 24 weeks, depending on the complexity of the experimental design, the number of compounds to be tested, and the depth of molecular analyses requested. Custom projects may require additional time for model development and optimization.
Why Choose Us?
Choosing CBL for your ET research means partnering with a team that combines deep scientific expertise with a proven track record in preclinical model development. Our commitment to scientific excellence, rigorous methodology, and client-centric approach sets us apart.
Experience the Advantage - Get a Quote Today
Customer Reviews: Real Impact, Real Results
"Unparalleled Mechanistic Insight: Using CBL's ET Lingo-1 knockout mice in our research has significantly improved our understanding of Lingo-1's role in axon integrity and Purkinje cell pathology. The precision of the model allowed us to pinpoint specific molecular pathways affected, which was crucial for our target validation efforts." - [Dr. An Mr], Principal Investigator
"Accelerated Compound Screening: The Lingo-1 KO mice provided by CBL were instrumental in our high-throughput screening of novel compounds. Their well-characterized phenotype allowed for rapid and reliable assessment of therapeutic efficacy, drastically cutting down our lead optimization time. We particularly appreciated the detailed genotyping protocol and the consistent health standards." - [Dr. Sh Pl], Senior Scientist
"Exceptional Support and Data Quality: The team at CBL offered outstanding scientific support throughout our project. Their expertise in behavioral phenotyping and molecular analysis ensured the highest quality data, which was essential for our grant applications. The insights gained from comparing Lingo-1 KO to wild-type controls were invaluable for confirming our hypotheses about Lingo-1's negative regulatory influence on neuronal survival." - [Dr. La Kn], Research Director
Lingo-1 Knockout Mice
The development of Lingo-1 knockout (KO) mice represents a significant leap forward in ET research. By genetically ablating the Lingo1 gene, these models allow researchers to investigate the precise consequences of Lingo-1 deficiency on neurological function and tremor development.
Key advantages and insights derived from Lingo-1 KO mice include:
Advantages | Description |
Elucidating Pathological Mechanisms | Lingo-1 KO mice exhibit increased axon integrity, highlighting Lingo-1's role in neuronal health and its potential contribution to the axonal pathology observed in ET. |
Validating Therapeutic Targets | These models are invaluable for validating Lingo-1 as a therapeutic target. Studies using Lingo-1 KO mice have demonstrated neuroprotective effects, such as enhanced survival of dopaminergic neurons in Parkinson's disease models, suggesting similar benefits in ET. |
Preclinical Drug Evaluation | Lingo-1 KO mice, or models where Lingo-1 expression is manipulated (e.g., harmaline-induced tremor models where Lingo-1 is overexpressed), serve as robust platforms for testing novel therapeutic compounds. For instance, studies have shown that agents capable of suppressing Lingo-1 overexpression can significantly reduce tremor severity and improve behavioral outcomes. This provides a direct path for identifying and validating potential drug candidates. |
Accelerating Lead Generation | By offering a physiologically relevant system to study Lingo-1's role and evaluate interventions, these models dramatically accelerate the lead generation process for ET therapeutics. Researchers can efficiently screen compounds, assess their efficacy, and gain critical insights into their mechanisms of action. |
What We Can Offer
At CBL, we provide a comprehensive, end-to-end solution for your ET research utilizing Lingo-1 knockout mice, ensuring scientific rigor and maximum impact for your projects. Our offerings are designed to be flexible and highly customizable to meet your unique research demands:
- Scalable Study Execution: From initial pilot studies to large-scale efficacy trials, we offer adaptable capacity to accommodate your research needs, ensuring consistent quality across all project sizes.
- Optimized Process Development: We employ efficient upstream and downstream processes for model generation, maintenance, behavioral phenotyping, and molecular analysis, streamlining your research timeline.
- Robust Colony Management: Our facilities are equipped for large-scale animal colony management, ensuring the availability of well-characterized Lingo-1 KO and control cohorts for your studies.
- Integrated Quality Systems: We adhere to a well-established quality system, incorporating principles of Quality-by-Design (QbD) and advanced process analytical techniques (PAT) throughout every stage of your project, from experimental design to data interpretation.
- Guaranteed Model Stability: We guarantee the genetic stability and health of our Lingo-1 Knockout mouse strains in our colonies, ensuring reliable and reproducible experimental outcomes.
- Customized Experimental Design: Our experts optimize experimental parameters and culture conditions to maximize the yield of meaningful data, offering flexibility in study modes (e.g., acute vs. chronic, various treatment regimens) to precisely address your research questions.
- Advanced Quality Control: High-standard quality control tools are employed to quantify and evaluate the quality of all data and experimental outcomes, providing you with robust and trustworthy results.
Related Services
o further support your neurological research and drug discovery efforts, CBL offers a suite of complementary services and related products:
- Neuroinflammation Assays
- Neurodegenerative Disease Models
- Biomarker Discovery & Validation
- Histology & Pathology Services
Ready to advance your Essential Tremor research? Our expert team is eager to discuss your project and provide tailored solutions.
Contact Our Team for More Information and to Discuss Your Project.

- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Muller Cell (Cat#: NCL2110P040)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)